Lack of interference by heparin with thrombolysis or binding of tissue-type plasminogen activator to thrombi. [electronic resource]
- Blood May 1988
- 1347-52 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0006-4971
Binding, Competitive Drug Interactions Fibrinolysis--drug effects Fibrinolytic Agents--metabolism Heparin--pharmacology Humans Protein Binding--drug effects Tissue Plasminogen Activator--metabolism alpha-2-Antiplasmin--analysis